Clin2
NCT07152600Possibly a fitNot yet recruiting

Steroids for severe adenovirus pneumonia in the ICU

Adenovirus Infections, Human

Treatments studied

Part of Infections, Lungs & breathing clinical trials.

This trial tests whether steroids (corticosteroids) can help adults with severe pneumonia caused by adenovirus (a common virus) who are in the ICU. The goal is to see if steroids reduce inflammation and improve recovery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
262 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You are in the intensive care unit (ICU).
  • You have a confirmed adenovirus infection (from a respiratory sample test).
  • You have severe pneumonia, meaning you need a breathing tube, have septic shock, or have several severe symptoms.
  • You have not had treatment that would disqualify you (e.g., vasopressors for shock, active bleeding, certain infections, or pregnancy).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07351500Not yet recruiting· Phase 3
Steroid treatment for severe flu pneumonia in intensive care

This study tests whether a steroid medicine can help adults in the ICU with severe flu pneumonia recover better. If you qualify, you may receive either the steroid or a placebo (dummy treatment) to see if it reduces inflammation and improves breathing.

NCT07152613Not yet recruiting· Phase 3
Steroids for severe Pneumocystis pneumonia in ICU patients

This trial tests whether giving steroids (anti-inflammatory medicines) to people with a severe lung infection called Pneumocystis pneumonia (PJP) can improve outcomes. It is for patients who are in the ICU and do not have HIV, which is a different group than typical PJP patients.

NCT07152587Not yet recruiting· Phase 2/Phase 3
Anti-inflammatory treatment for severe pneumonia in the ICU

This trial tests whether adding anti-inflammatory medicine (steroids) to usual care helps people with severe pneumonia recover faster. It only includes patients who are seriously ill in the ICU, and the goal is to find the best way to reduce lung inflammation and improve outcomes.

NCT07352865Not yet recruiting· Phase 3
Steroid treatment for severe psittacosis pneumonia in the ICU

This trial tests whether giving corticosteroids (anti-inflammatory medicines) to adults with severe psittacosis pneumonia in the ICU can help them recover better. It aims to see if this treatment reduces the need for breathing support or improves survival.

NCT07357935Not yet recruiting· Phase 1/Phase 2
Personalized steroids for severe pneumonia breathing failure

This study tests whether giving a personalized dose of steroids (anti-inflammatory medicine) early can help people with severe pneumonia-related breathing failure recover faster. It compares different steroid doses based on your body's inflammation and immune response.

NCT07511582Recruiting· Phase 2
Steroids for severe breathing problems in the ICU

This study tests whether a corticosteroid (a type of anti-inflammatory medicine) can help people with severe breathing problems or serious infections who have a specific 'hyperinflammatory' pattern. If you are in the ICU on a ventilator, this trial may be an option for you.

Beijing, Beijing Municipality

Hear when a new Adenovirus Infections, Human trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.